TABLE OF CONTENT: 1. Introduction 1.1. Research Scope 1.2. Market Segmentation 1.3. Research Methodology 1.4. Definitions and Assumptions 2. Executive Summary 3. Market Dynamics 3.1. Market Drivers 3.2. Market Restraints 3.3. Market Opportunities 4. Key Insights 4.1 Porter's five forces analysis 4.2 Top 3 players working in market space 4.3 Key developments (Merger, Acquisitions,etc.) 4.4 Technological Advancements 5. Global Molecular Diagnostics Market Analysis, Insights and Forecast, 2014-2025 5.1. Key Findings/Summary 5.2. Market Analysis, Insights and Forecast –By Product Type 5.2.1 Instruments 5.2.2 Reagents & Consumables 5.3. Market Analysis, Insights and Forecast –By Application 5.3.1 Infectious Disease 5.3.2 Blood Screening 5.3.3 Histology 5.3.4 Oncology 5.3.5 Others 5.4 Market Analysis, Insights and Forecast – By Technique 5.4.1 Amplification Techniques 5.4.2 Hybridization Techniques 5.4.3 Sequencing Techniques 5.4.4 Others 5.5. Market Analysis, Insights and Forecast –By End User 5.5.1 Clinical & Pathology Labs 5.5.2 Hospitals 5.5.3 Others 5.6. Market Analysis, Insights and Forecast – By Region 5.6.1 North America 5.6.2 Europe 5.6.3 Asia Pacific 5.6.4 Middle East & Africa 5.6.5 Latin America 6. North America Molecular Diagnostics Market Analysis, Insights and Forecast,2014-2025 6.1. Key Findings / Summary 6.2. Market Analysis – By Product Type 6.2.1 Instruments 6.2.2 Reagents & Consumables 6.3. Market Analysis – By Application 6.3.1 Infectious Disease 6.3.2 Blood Screening 6.3.3 Histology 6.3.4 Oncology 6.3.5 Others 6.4. Market Analysis – By Technique 6.4.1 Amplification Techniques 6.4.2 Hybridization Techniques 6.4.3 Sequencing Techniques 6.4.4 Others 6.5. Market Analysis – By End User 6.5.1 Clinical & Pathology Labs 6.5.2 Hospitals 6.5.3 Others 6.6. Market Analysis – By Country 6.6.1 U.S. 6.6.2 Canada 7. Europe Molecular Diagnostics Market Analysis, Insights and Forecast, 2014-2025 7.1. Key Findings / Summary 7.2. Market Analysis – By Product Type 7.2.1 Instruments 7.2.2 Reagents & Consumables 7.3. Market Analysis – By Application 7.3.1 Infectious Disease 7.3.2 Blood Screening 7.3.3 Histology 7.3.4 Oncology 7.3.5 Others 7.4. Market Analysis – By Technique 7.4.1 Amplification Techniques 7.4.2 Hybridization Techniques 7.4.3 Sequencing Techniques 7.4.4 Others 7.5. Market Analysis – By End User 7.5.1 Clinical & Pathology Labs 7.5.2 Hospitals 7.5.3 Others 7.6. Market Analysis – By Country/ Sub-region 7.6.1 U.K 7.6.2 Germany 7.6.3 France 7.6.4 Italy 7.6.5 Spain 7.6.6 Scandinavia 7.6.7 Rest of Europe 8. Asia Pacific Molecular Diagnostics Market Analysis, Insights and Forecast,2014-2025 8.1. Key Findings/Summary 8.2. Market Analysis – By Product Type 8.2.1 Instruments 8.2.2 Reagents & Consumables 8.3. Market Analysis – By Application 8.3.1 Infectious Disease 8.3.2 Blood Screening 8.3.3 Histology 8.3.4 Oncology 8.3.5 Others 8.4. Market Analysis – By Technique 8.4.1 Amplification Techniques 8.4.2 Hybridization Techniques 8.4.3 Sequencing Techniques 8.5. Market Analysis – By End User 8.5.1 Clinical & Pathology Labs 8.5.2 Hospitals 8.5.3 Others 8.6. Market Analysis – By Country/ Sub-region 8.6.1 Japan 8.6.2 China 8.6.3 India 8.6.4 Australia 8.6.5 Southeast Asia 8.6.6 Rest of Asia Pacific 9. Middle East & Africa Molecular Diagnostics Market Analysis, Insights and Forecast, 2014-2025 9.1. Key Findings/Summary 9.2. Market Analysis – By Product Type 9.2.1 Instruments 9.2.2 Reagents& Consumables 9.3. Market Analysis – By Application 9.3.1 Infectious Disease 9.3.2 Blood Screening 9.3.3 Histology 9.3.4 Oncology 9.3.5 Others 9.4. Market Analysis – By Technique 9.4.1 Amplification Techniques 9.4.2 Hybridization Techniques 9.4.3 Sequencing Techniques 9.4.4 Others 9.5. Market Analysis – By End User 9.5.1 Clinical & Pathology Labs 9.5.2 Hospitals 9.5.3 Others 9.6. Market Analysis – By Country/ Sub-region 9.6.1 South Africa 9.6.2 GCC 9.6.2 Rest of Middle East & Africa 10.Latin America Molecular Diagnostics Market Analysis, Insights and Forecast, 2014-2025 10.1. Key Findings/ Summary 10.2. Market Analysis – By Product Type 10.2.1 Instruments 10.2.2 Reagents & Consumables 10.3. Market Analysis – By Application 10.3.1 Infectious Disease 10.3.2 Blood Screening 10.3.3 Histology 10.3.4 Oncology 10.3.5 Others 10.4. Market Analysis – By Technique 10.4.1 Amplification Techniques 10.4.2 Hybridization Techniques 10.4.3 Sequencing Techniques 10.4.4 Others 10.5. Market Analysis – By End User 10.5.1 Clinical & Pathology Labs 10.5.2 Hospitals 10.5.3 Others 10.6. Market Analysis– By Country 10.6.1 Brazil 10.6.2 Mexico 10.6.3 Rest of Latin America 11.Competitive Analysis 11.1. Key Industry Developments 11.2. Global Market Share Analysis (2017) 11.3. Competition Dashboard 11.4. Comparative Analysis – Major Players 11.5. Company Profiles (Overview, Products & Services, SWOT Analysis, Recent Developments, Strategies, Financials (Based on Availability)) 11.5.1 bioMérieux SA. 11.5.2 BD 11.5.3 Danher 11.5.4 GrifolsS.A. 11.5.5 Hologic Inc. 11.5.6 Novartis AG 11.5.7 QIAGEN 11.5.8 Siemens Healthcare GmbH 11.5.9 Hoffmann-La Roche Ltd. 11.5.10 Other Prominent Players 12. Strategic Recommendations

BioMérieux SA. BD Danaher Grifols, S.A. Hologic Inc. Novartis AG QIAGEN Siemens Healthcare GmbH Hoffmann-La Roche Ltd. Other players